Could a belly strap replace clinic visits for High-Risk pregnancies?

NCT ID NCT06822439

Recruiting now Knowledge-focused Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a simple fetal ECG monitor worn at home can effectively track the health of babies in high-risk pregnancies. Fifty pregnant women who need weekly fetal testing will use the device for 30-minute sessions, three times a week, starting at 32 weeks. The goal is to see if this approach is acceptable and practical for patients and doctors, potentially reducing the burden of frequent clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fetal ECG monitoring device
What this could lead to: If successful, this could show that remote fetal monitoring is a practical option for high-risk pregnancies, potentially reducing the need for frequent clinic visits.
What could go wrong: This is a small pilot study with only 50 participants, so results may not apply to all pregnant women. The device may not work well for everyone or may be difficult to use at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES HIGH-RISK PREGNANCY HYPERTENSION REMOTE PATIENT MONITORING

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.